학술논문

A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis
Document Type
Article
Source
In JHEP Reports January 2023 5(1)
Subject
Language
ISSN
2589-5559